Skip to main content

Pharma News

Get the latest news from world and India’s leading pharmaceutical companies Pharma Industry, pharmaceutical marketing, generic drugs, and Complete news for Pharmacy and Life Sciences professionals.

  • Researchers at Southern Medical University have discovered a molecule that can help clinicians predict survival time of people afflicted with gastric cancer, a significant health problem in developing countries which is typically associated with late-stage diagnosis and high mortality. The findings appeared in The American Journal of Pathology.

  • AstraZeneca, a global, innovation-driven biopharmaceutical business, and The University of Manchester, a member of the prestigious Russell Group of British universities collaborate to deliver personalised healthcare for cancer patients. The five-year agreement will see the organisations apply clinical trial bioinformatics to better identify the right cancer treatment for the right patient at the right time. As part of the collaboration, AstraZeneca will provide a total of £11.5 million.

  • (Business Wire India); A clinical study conducted on 50 women in the age group of 18-45 years showed significant results in the treatment of polycystic ovary syndrome with the use of Fenugreek seed extract (Furocyst). The average BMI of the study population was 23.88 and had adequate hepatic, renal and haematological functions. At the time of enrolment, most of the patients had prolonged menstrual cycle (81%) and a few had irregular cycle (10%). Rest of the patients (10%) had primary infertilities.

    [adsense:336x280:8701650588]

  • Bausch & Lomb launch  Obagi’s blockbuster products like Thermage, Fraxel, Vaser & Clear + Brilliant and few more offerings in the pipeline. This strategic move of expanding in the premium skincare segment, would further strengthen Bausch & Lomb’s position in the INR 285 - 290 billion beauty care market, growing at a rate 15 to 20 per cent per annum (As per FICCI Wellness Report 2013).

  • A new research find that Bacteria living in the gut may impact an individual's weight, fat and good cholesterol levels. The findings of the study suggest that microbes in the gut are strongly linked to the blood level of HDL (good cholesterol) and triglycerides. The study appeared in Circulation Research. Bacteria in the gut contributed to 4.6% of the difference in body fat, 6% in triglycerides and 4% in HDL.

Subscribe to Pharma News